Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a post on LinkedIn about a recent article by Rui-Xiang Zeng et al., published in JACC Journals:
“Interesting to see cholesterol and inflammation portrayed as equal partners in atherosclerosis.
The problem is that the evidence is not remotely symmetrical.
For LDL-C lowering we have decades of randomized trials—4S, HPS, PROVE-IT, IMPROVE-IT, FOURIER, ODYSSEY, CLEAR Outcomes—consistently showing that lowering LDLc reduces cardiovascular events.
For anti-inflammatory therapy?
A small handful of trials, modest benefits, and sometimes meaningful safety concerns.
Inflammation matters.
No serious scientist denies that.
But putting cholesterol and inflammation on the same evidentiary level is a bit like calling a tie when one side is supported by a vast body of randomized trial evidence and the other by only limited clinical proof.
LDL isn’t just part of the story.
It’s the only target that has repeatedly proven in randomized trials that moving it changes outcomes.
Evidence first.
Symmetry later.”
Title: Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy
Authors: Rui-Xiang Zeng, Sha Li, Jian-Jun Li
Read the Full Article on JACC Journals
Other posts about Pablo Corral on Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly